Association of serum lipid levels with diabetic retinopathy
AIM
To assess the association between serum lipids and diabetic retinopathy (DR).
METHODS
Sixty-one diabetic patients without retinopathy(NDR), 55 diabetic patients with non-proliferative retinopathy(NPDR) and 75 diabetic patients with proliferative retinopathy (PDR) according to ETDRS grading scale were enrolled in this study. Total cholesterol, high density lipoprotein (HDL), low density lipoprotein (LDL), very low density lipoprotein (VLDL) and triglyceride values were compared between the groups.
RESULTS
The groups were well-balanced in terms of age and gender (P=0.071, P=0.265 respectively). The mean HbA1c values were significantly lower in NDR group than the NPDR and PDR groups (P=0.004, P=0.009 respectively). Mean total cholesterol, triglyceride, LDL, HDL and VLDL levels were not significantly different between the groups (P=0.693, P=0.774, P=0.644, P=0.910 and P=0.967 respectively, one way ANOVA). Mean total cholesterol, triglyceride, LDL, HDL and VLDL levels were not significantly different between the patients with ME and patients without ME (P=0.622, P=0.113, P=0.955, P=0.735 and P=0.490 respectively, t-test). The mean blood glucose significantly correlated with total cholesterol (r=0.173, P=0.017) and LDL (r=0.190, P=0.008). The mean HbA1c significantly correlated with total cholesterol (r=0.158, P=0.030) and triglyceride (r=0.148, P=0.042).
CONCLUSION
Serum lipid levels were not significantly associated with the severity of DR or existence of ME despite the significant correlation between the mean blood glucose, HbA1c and total cholesterol.
Abstract
AIM
To assess the association between serum lipids and diabetic retinopathy (DR).
METHODS
Sixty-one diabetic patients without retinopathy(NDR), 55 diabetic patients with non-proliferative retinopathy(NPDR) and 75 diabetic patients with proliferative retinopathy (PDR) according to ETDRS grading scale were enrolled in this study. Total cholesterol, high density lipoprotein (HDL), low density lipoprotein (LDL), very low density lipoprotein (VLDL) and triglyceride values were compared between the groups.
RESULTS
The groups were well-balanced in terms of age and gender (P=0.071, P=0.265 respectively). The mean HbA1c values were significantly lower in NDR group than the NPDR and PDR groups (P=0.004, P=0.009 respectively). Mean total cholesterol, triglyceride, LDL, HDL and VLDL levels were not significantly different between the groups (P=0.693, P=0.774, P=0.644, P=0.910 and P=0.967 respectively, one way ANOVA). Mean total cholesterol, triglyceride, LDL, HDL and VLDL levels were not significantly different between the patients with ME and patients without ME (P=0.622, P=0.113, P=0.955, P=0.735 and P=0.490 respectively, t-test). The mean blood glucose significantly correlated with total cholesterol (r=0.173, P=0.017) and LDL (r=0.190, P=0.008). The mean HbA1c significantly correlated with total cholesterol (r=0.158, P=0.030) and triglyceride (r=0.148, P=0.042).
CONCLUSION
Serum lipid levels were not significantly associated with the severity of DR or existence of ME despite the significant correlation between the mean blood glucose, HbA1c and total cholesterol.
Acknowledgments
Clayton Scanlon is appreciated for assistance with English editing. This report was presented at 45 National Congress of Turkish Society of Ophthalmology (5-9 October 2011)
REFERENCES
References
- 1. West KM, Erdreich LJ, Stober JAA detailed study of risk factors for retinopathy and nephropathy in diabetes. Diabetes. 1980;29(7):501–508.[PubMed][Google Scholar]
- 2. Landmesser U, Hornig B, Drexler HEndothelial dysfunction in hypercholesterolemia: mechanisms, pathophysiological importance, and therapeutic interventions. Semin Thromb Hemost. 2000;26(5):529–537.[PubMed][Google Scholar]
- 3. Chew EY, Klein ML, Ferris FL, III, Remaley NA, Murphy RP, Chantry K, Hoogwerf BJ, Miller D. Association of elevated serum lipid levels with retinal hard exudate in diabetic retinopathy. Early Treatment Diabetic Retinopathy Study (ETDRS) Report 22. Arch Ophthalmol. 1996;114(9):1079–1084.[PubMed]
- 4. Rema M, Srivastava BK, Anitha B, Deepa R, Mohan VAssociation of serum lipids with diabetic retinopathy in urban South Indians-the Chennai Urban Rural Epidemiology Study (CURES) Eye Study-2. Diabet Med. 2006;23(9):1029–1036.[PubMed][Google Scholar]
- 5. Wong TY, Klein R, Islam FM, Cotch MF, Folsom AR, Klein BE, Sharrett AR, Shea SDiabetic retinopathy in a multi-ethnic cohort in the United States. Am J Ophthalmol. 2006;141(3):446–455.[Google Scholar]
- 6. Tapp RJ, Shaw JE, Harper CA, de Courten MP, Balkau B, McCarty DJ, Taylor HR, Welborn TA, Zimmet PZ, AusDiab Study Group The prevalence of and factors associated with diabetic retinopathy in the Australian population. Diabetes Care. 2003;26(6):1731–1737.[PubMed]
- 7. Wong TY, Cheung N, Tay WT, Wang JJ, Aung T, Saw SM, Lim SC, Tai ES, Mitchell PPrevalence and risk factors for diabetic retinopathy: the Singapore Malay Eye Study. Ophthalmology. 2008;115(11):1869–1875.[PubMed][Google Scholar]
- 8. Grading diabetic retinopathy from stereoscopic colour fundus photographs-an extension of the modified Airlie House classification. ETDRS report number 10. Early Treatment of Diabetic Retinopathy Study Research Group. Ophthalmology. 1991;98(5 Suppl):786–806.[PubMed]
- 9. Focal photocoagulation treatment of diabetic macular edema. Relationship of treatment effect to fluorescein angiographic and other retinal characteristics at baseline: ETDRS Report Number 19. Early Treatment Diabetic Retinopathy Study Research Group. Arch Ophthalmol. 1995;113(9):1144–1155.[PubMed]
- 10. Schalkwijk CG, Stehouwer CDVascular complications in diabetes mellitus: the role of endothelial dysfunction. Clin Sci (Lond) 2005;109(2):143–159.[PubMed][Google Scholar]
- 11. Baynes JW, Thorpe SRGlycoxidation and lipoxidation in atherogenesis. Free Radic Biol Med. 2000;28(12):1708–1016.[PubMed][Google Scholar]
- 12. Benarous R, Sasongko MB, Qureshi S, Fenwick E, Dirani M, Wong TY, Lamoureux ELDifferential association of serum lipids with diabetic retinopathy and diabetic macular edema. Invest Ophthalmol Vis Sci. 2011;52(10):7464–7469.[PubMed][Google Scholar]
- 13. Sachdev N, Sahni AAssociation of systemic risk factors with the severity of retinal hard exudates in a north Indian population with type 2 diabetes. J Postgrad Med. 2010;56(1):3–6.[PubMed][Google Scholar]
- 14. Raman R, Rani PK, Kulothungan V, Rachepalle SR, Kumaramanickavel G, Sharma TInfluence of serum lipids on clinically significant versus nonclinically significant macular edema: SN-DREAMS Report number 13. Ophthalmology. 2010;117(4):766–772.[PubMed][Google Scholar]
- 15. Miljanovic B, Glynn RJ, Nathan DM, Manson JE, Schaumberg DAA prospective study of serum lipids and risk of diabetic macular edema in type 1 diabetes. Diabetes. 2004;53(11):2883–2892.[PubMed][Google Scholar]
- 16. Idiculla J, Nithyanandam S, Joseph M, Mohan VA, Vasu U, Sadiq MSerum lipids and diabetic retinopathy: A cross-sectional study. Indian J Endocrinol Metab. 2012;16(Suppl 2):S492–494.[Google Scholar]
- 17. Ozer PA, Unlu N, Demir MN, Hazirolan DO, Acar MA, Duman SSerum lipid profile in diabetic macular edema. J Diabetes Complications. 2009;23(4):244–248.[PubMed][Google Scholar]
- 18. Hove MN, Kristensen JK, Lauritzen T, Bek TThe prevalence of retinopathy in an unselected population of type 2 diabetes patients from Arhus County, Denmark. Acta Ophthalmol Scand. 2004;82(4):443–438.[PubMed][Google Scholar]
- 19. Ebeling P, Koivisto VAOccurrence and interrelationships of complications in insulin-dependent diabetes in Finland. Acta Diabetol. 1997;34(1):33–38.[PubMed][Google Scholar]
- 20. Larsson LI, Alm A, Lithner F, Dahlén G, Bergström RThe association of hyperlipidemia with retinopathy in diabetic patients aged 15-50 years in the county of Umeå Acta Ophthalmol Scand. 1999;77(5):585–591.[PubMed][Google Scholar]
- 21. Keech AC, Mitchell P, Summanen PA, O'Day J, Davis TM, Moffitt MS, Taskinen MR, Simes RJ, Tse D, Williamson E, Merrifield A, Laatikainen LT, d'Emden MC, Crimet DC, O'Connell RL, Colman PG, FIELD study investigators Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomized controlled trial. Lancet. 2007;370(9600):1687–1697.[PubMed]
- 22. Wong TY, Klein R, Islam FM, Cotch MF, Folsom AR, Klein BE, Sharrett AR, Shea SDiabetic retinopathy in a multi-ethnic cohort in the United States. Am J Ophthalmol. 2006;141(3):446–455.[Google Scholar]
- 23. Sivaprasad S, Gupta B, Crosby-Nwaobi R, Evans JPrevalence of diabetic retinopathy in various ethnic groups: a worldwide perspective. Surv Ophthalmol. 2012;57(4):347–370.[PubMed][Google Scholar]

